Southern Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Southern Capital Advisors's AMGN Position: Q2 2026 in Review
Southern Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 1,168 shares worth $423K. The position accounts for 0.18% of the portfolio, ranked #51.
Southern Capital Advisors first reported a position in AMGN in Q1 2022 and has held it in 14 quarters since. The position peaked at $442K in Q2 2024. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Southern Capital Advisors held 1,168 shares of Amgen worth $423K as of Q2 2026.
- Southern Capital Advisors left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.18% of Southern Capital Advisors's portfolio in Q2 2026, its #51 holding.
- Southern Capital Advisors first reported a position in Amgen in Q1 2022 and has held it in 14 quarters since.
- Southern Capital Advisors's Amgen position peaked at $442K in Q2 2024.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Southern Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.